Latest Insights - page 75 | BiopharmaTrend

Eight Approaches to Leveraging AI in Clinical Trials with the Key Industry Innovators

In the ongoing pursuit of new drugs and medical treatments, the pharmaceutical sector faces a complex task: verifying the safety and efficacy of these potential advancements. Clinical trials, long-drawn, expensive, …

Continue ›››

Maturing Pharma 4.0: How Digital Transformation Continues To Reshape Pharmaceuticals

The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data available. The requirement for more people to maintain ‘physical distance’ …

Continue ›››

Will Biologics Surpass Small Molecules In The Pharmaceutical Race?

The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked a new era in the pharmaceutical industry. Modern advances in …

Continue ›››

From Data to Treatment: Medidata's Fareed Melhem Discusses AI's Impact on Clinical Trials

As the potential of artificial intelligence (AI) continues to unfold, how is it revolutionizing the intricate landscape of clinical trials? How can vast reservoirs of data be harnessed to enhance …

Continue ›››

How Lithuania's Deep Tech Ecosystem Is Fueling the Country's Life Sciences Boom

From gene editing and artificial intelligence (AI)-driven protein design, to cutting-edge 3D bioprinting, tissue engineering and microfluidics – Lithuania appears to be a home for a vibrant ecosystem of companies …

Continue ›››

Blending Biology and AI: Dr. Markus Gershater on the Future of Life Sciences

In the dynamic field of life sciences, both biological research and AI are coming together to alter our perspective on life at its most basic level. Dr. Markus Gershater, Co-founder …

Continue ›››

U.S. Frontiers in Biotech: Interview with Abigail Kukura about Strategy, Science, and the Road Ahead

Biotechnology is more than just an emerging scientific frontier, it also impacts global economy, competition, and societal transformation. To learn about a more expanded context of biotech innovations in the …

Continue ›››

How AbbVie Addresses Individuals Living with Migraine in Europe: Interview with Michael Seminerio

In August, AbbVie has secured European Commission (EC) approval for AQUIPTA® (atogepant) as a preventive treatment for adults experiencing four or more migraine days per month, making it the European …

Continue ›››

Navigating the UK Health Technology Market: Trends and Opportunities

The UK’s health technology market has seen unprecedented levels of M&A transactions and fundraising. The Covid-19 pandemic acted as a catalyst, accelerating the adoption of digital health solutions, and sparking …

Continue ›››

The CRO Industry in Flux: Navigating Technology, Business Models, and Trends in Pharma R&D Outsourcing

As the global pharmaceutical landscape continues to transform at a breathtaking pace, it becomes crucial to examine the phenomenon that is powering this change - Contract Research Organizations (CROs). With …

Continue ›››

AI Drug Discovery: Key Trends and Developments in Pharmaceutical Industry

AI in Drug Discovery at a Glance The ongoing rise of artificial intelligence (AI) is significantly impacting various industries, with the pharmaceutical and biotech sectors being no exception. It is …

Continue ›››

The Explosion of Therapeutic Modalities: Small Molecules, Biologics, and Everything in Between

Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, up to 90% of the on-the-market therapeutics are small molecules, …

Continue ›››